UBS Group’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
ACA
CIA
CAI
SIC
KA
UBS Group's IBDX Position: Q2 2026 in Review
UBS Group increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 3.2% in Q2 2026, buying an estimated $958K and bringing the position to 1,208,903 shares worth $30.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2252.
UBS Group first reported a position in IBDX in Q3 2022 and has held it in 16 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- UBS Group held 1,208,903 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $30.5M as of Q2 2026.
- UBS Group bought 38,023 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $958K.
- iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2252 holding.
- UBS Group first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2022 and has held it in 16 quarters since.
- 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.